Technical analysis of Cumberland Pharmaceuticals Inc. (CPIX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strategic focus areas include acute hospital care, gastroenterology, rheumatology, and oncology, with operations spanning both the United States and global markets. The company's existing product line includes: Acetadote: an injectable solution for treating acetaminophen poisoning.
Price Performance
| 1 month | -8.52% |
| 3 months | +22.03% |
| Year-to-date | +75.38% |
| 1 year | +116.10% |
| 3 years | +233.97% |
52-Week Range
| 52-week High | $9.28 |
| 52-week Low | $1.85 |
| Avg Volume (90d) | 98K |
Technical Indicators
| SMA 50 | $7.23 |
| SMA 200 | $4.97 |
| Beta | -0.33 |
| 30-day Volatility (annualised) | 83.4% |
| Price vs SMA 50 | -3.4% |
| Price vs SMA 200 | +40.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.99 | |
| 2025-11 | $2.26 | -24.4% |
| 2025-12 | $3.98 | +76.1% |
| 2026-01 | $3.75 | -5.8% |
| 2026-02 | $4.92 | +31.2% |
| 2026-03 | $3.25 | -33.9% |
| 2026-04 | $4.19 | +28.9% |
| 2026-05 | $6.15 | +46.8% |
| 2026-06 | $6.48 | +5.4% |
| 2026-07 | $6.68 | +3.1% |
| 2026-08 | $6.69 | +0.1% |
| 2026-09 | $6.98 | +4.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | | $40M |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
Price
| Price | $6.98 |
| Market Cap | $105M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 6.05 |
| EV / EBITDA | -17.72 |
| Dividend Yield | 21.30% |
Financial Health
| Debt / Equity | 0.27 |
| Current Ratio | 0.96 |